Scot Styren

3.6k total citations · 2 hit papers
31 papers, 2.9k citations indexed

About

Scot Styren is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Scot Styren has authored 31 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 7 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Scot Styren's work include Alzheimer's disease research and treatments (18 papers), Dementia and Cognitive Impairment Research (7 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Scot Styren is often cited by papers focused on Alzheimer's disease research and treatments (18 papers), Dementia and Cognitive Impairment Research (7 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Scot Styren collaborates with scholars based in United States, Belgium and Sweden. Scot Styren's co-authors include Steven T. DeKosky, Joseph Rogers, W H Civin, Judith Luber‐Narod, Stephen W. Scheff, Patrick M. Kochanek, William E. Klunk, Jeffrey H. Kordower, James R. Goss and Elliott J. Mufson and has published in prestigious journals such as The Journal of Comparative Neurology, Annals of Neurology and Brain Research.

In The Last Decade

Scot Styren

30 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease

1988 601 citations Joseph Rogers, Judith Luber‐Narod et al. Neurobiology of Aging profile →
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment

2002 560 citations Steven T. DeKosky, Miloš D. Ikonomović et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scot Styren United States	19	1.6k	885	838	706	458	31	2.9k
Manuela Polydoro United States	23	1.9k 1.2×	753 0.9×	926 1.1×	960 1.4×	381 0.8×	28	3.2k
Rajesh N. Kalaria United States	35	1.6k 1.0×	1.1k 1.3×	1.3k 1.5×	870 1.2×	392 0.9×	65	3.9k
Rena Li United States	23	1.5k 1.0×	809 0.9×	744 0.9×	513 0.7×	257 0.6×	60	2.8k
Lucia Dumitrescu‐Ozimek Germany	11	1.5k 0.9×	1.2k 1.4×	1.0k 1.2×	701 1.0×	354 0.8×	12	3.0k
Liying Han China	21	1.4k 0.9×	587 0.7×	943 1.1×	540 0.8×	230 0.5×	51	3.2k
Hala Kazi United States	11	1.6k 1.1×	611 0.7×	922 1.1×	729 1.0×	273 0.6×	11	3.1k
Kiran Bhaskar United States	27	1.9k 1.2×	1.3k 1.4×	1.1k 1.3×	621 0.9×	365 0.8×	52	3.3k
Estibaliz Capetillo‐Zarate Spain	26	1.4k 0.9×	784 0.9×	791 0.9×	797 1.1×	321 0.7×	44	2.6k
Shuko Takeda Japan	31	2.0k 1.3×	901 1.0×	1.0k 1.2×	676 1.0×	403 0.9×	58	3.4k
Tom Kasten United States	15	2.2k 1.4×	765 0.9×	846 1.0×	617 0.9×	348 0.8×	19	3.3k

Countries citing papers authored by Scot Styren

Since Specialization

Citations

This map shows the geographic impact of Scot Styren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scot Styren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scot Styren more than expected).

Fields of papers citing papers by Scot Styren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scot Styren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scot Styren. The network helps show where Scot Styren may publish in the future.

Co-authorship network of co-authors of Scot Styren

This figure shows the co-authorship network connecting the top 25 collaborators of Scot Styren. A scholar is included among the top collaborators of Scot Styren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scot Styren. Scot Styren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Merker, Vanessa L., Justin T. Jordan, Ina Ly, et al.. (2022). Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related pain. Contemporary Clinical Trials. 121. 106900–106900. 3 indexed citations

Ivanoiu, Adrian, Jérémie Pariente, Kevin Booth, et al.. (2016). Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies. Alzheimer s Research & Therapy. 8(1). 24–24. 33 indexed citations

Russu, Alberto, Mahesh N. Samtani, Steven Xu, et al.. (2016). Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer’s Disease Trials of Bapineuzumab. Journal of Alzheimer s Disease. 53(2). 535–546. 4 indexed citations

Liu, Enchi, Ajibade Ashaye, Karin Travers, et al.. (2014). P1‐147: A PROSPECTIVE, SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSES TO EVALUATE GLOBAL AND REGIONAL BRAIN VOLUMES BY STRUCTURAL MRI AS BIOMARKERS OF ALZHEIMER'S DISEASE (AD) PROGRESSION. Alzheimer s & Dementia. 10(4S_Part_9).

Burstein, Aaron H., Qinying Zhao, Joel Ross, et al.. (2013). Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease. Clinical Neuropharmacology. 36(1). 8–13. 43 indexed citations

Mufson, Elliott J., Miloš D. Ikonomović, Scot Styren, et al.. (2003). Preservation of Brain Nerve Growth Factor in Mild Cognitive Impairment and Alzheimer Disease. Archives of Neurology. 60(8). 1143–1143. 51 indexed citations

DeKosky, Steven T., Miloš D. Ikonomović, Scot Styren, et al.. (2002). Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Annals of Neurology. 51(2). 145–155. 560 indexed citations breakdown →

Link, Christopher D., Carolyn J. Johnson, Virginia Fonte, et al.. (2001). Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiology of Aging. 22(2). 217–226. 126 indexed citations

Styren, Scot, et al.. (2000). X-34, A Fluorescent Derivative of Congo Red: A Novel Histochemical Stain for Alzheimer's Disease Pathology. Journal of Histochemistry & Cytochemistry. 48(9). 1223–1232. 230 indexed citations

10.

Zou, Lanling, Lynn A. Burmeister, Scot Styren, Patrick M. Kochanek, & Steven T. DeKosky. (1998). Up‐Regulation of Type 2 Iodothyronine Deiodinase mRNA in Reactive Astrocytes Following Traumatic Brain Injury in the Rat. Journal of Neurochemistry. 71(2). 887–890. 26 indexed citations

11.

Goss, James R., Mark E. O’Malley, Lanling Zou, et al.. (1998). Astrocytes Are the Major Source of Nerve Growth Factor Upregulation Following Traumatic Brain Injury in the Rat. Experimental Neurology. 149(2). 301–309. 130 indexed citations

12.

Styren, Scot, et al.. (1997). Epidermal Growth Factor Receptor Expression in Skin Does Not Predict Dementia in the Elderly. Dementia and Geriatric Cognitive Disorders. 9(1). 20–23. 5 indexed citations

13.

DeKosky, Steven T., Scot Styren, Mark E. O’Malley, et al.. (1996). Interleukm‐1 receptor antagonist suppresses neurotrophin response in injured rat brain. Annals of Neurology. 39(1). 123–127. 84 indexed citations

14.

DeKosky, Steven T., Stephen W. Scheff, & Scot Styren. (1996). Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change. PubMed. 5(4). 417–421. 330 indexed citations

15.

Goss, James R., Scot Styren, Peter D. Miller, et al.. (1995). Hypothermia Attenuates the Normal Increase in Interleukin 1β RNA and Nerve Growth Factor Following Traumatic Brain Injury in the Rat. Journal of Neurotrauma. 12(2). 159–167. 138 indexed citations

16.

DeKosky, Steven T., James R. Goss, Peter D. Miller, et al.. (1994). Upregulation of Nerve Growth Factor Following Cortical Trauma. Experimental Neurology. 130(2). 173–177. 104 indexed citations

17.

Styren, Scot, Steven T. DeKosky, Joseph Rogers, & E. J. Mufson. (1993). Epidermal growth factor receptor expression in demented elderly: localization to vascular endothelial cells of brain, pituitary and skin. Brain Research. 615(2). 181–190. 17 indexed citations

18.

Styren, Scot, et al.. (1990). Epidermal growth factor receptor expression in demented and aged human brain. Brain Research. 512(2). 347–352. 30 indexed citations

19.

Styren, Scot, W H Civin, & Joseph Rogers. (1990). Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Experimental Neurology. 110(1). 93–104. 152 indexed citations

20.

Rogers, Joseph, Judith Luber‐Narod, Scot Styren, & W H Civin. (1988). Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiology of Aging. 9(4). 339–349. 601 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact